Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

597 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B.
Pipe SW, Leebeek FWG, Recht M, Key NS, Castaman G, Miesbach W, Lattimore S, Peerlinck K, Van der Valk P, Coppens M, Kampmann P, Meijer K, O'Connell N, Pasi KJ, Hart DP, Kazmi R, Astermark J, Hermans CRJR, Klamroth R, Lemons R, Visweshwar N, von Drygalski A, Young G, Crary SE, Escobar M, Gomez E, Kruse-Jarres R, Quon DV, Symington E, Wang M, Wheeler AP, Gut R, Liu YP, Dolmetsch RE, Cooper DL, Li Y, Goldstein B, Monahan PE. Pipe SW, et al. Among authors: van der valk p. N Engl J Med. 2023 Feb 23;388(8):706-718. doi: 10.1056/NEJMoa2211644. N Engl J Med. 2023. PMID: 36812434 Clinical Trial.
Prevalence of COVID-19 related hospitalizations and mortality in adults aged ≥40 years with haemophilia: A survey from Europe.
Hermans C, Astermark J, Carvalho M, Dolan G, d'Oiron R, Fontana P, Holme PA, Kenet G, Klamroth R, Mancuso ME, Marquardt N, Nunez R, Katsarou O, Pabinger-Fasching I, Quintavalle G, Rodgers R, van der Valk P, Windyga J, Jimenez Yuste V, Preložnik Zupan I. Hermans C, et al. Among authors: van der valk p. Haemophilia. 2023 May;29(3):913-916. doi: 10.1111/hae.14761. Epub 2023 Feb 18. Haemophilia. 2023. PMID: 36802089 No abstract available.
Etranacogene dezaparvovec gene therapy for haemophilia B (HOPE-B): 24-month post-hoc efficacy and safety data from a single-arm, multicentre, phase 3 trial.
Coppens M, Pipe SW, Miesbach W, Astermark J, Recht M, van der Valk P, Ewenstein B, Pinachyan K, Galante N, Le Quellec S, Monahan PE, Leebeek FWG; HOPE-B Investigators. Coppens M, et al. Among authors: van der valk p. Lancet Haematol. 2024 Apr;11(4):e265-e275. doi: 10.1016/S2352-3026(24)00006-1. Epub 2024 Mar 1. Lancet Haematol. 2024. PMID: 38437857 Clinical Trial.
Invasive procedures and surgery following etranacogene dezaparvovec gene therapy in people with hemophilia B.
O'Connell N, van der Valk P, Le Quellec S, Gomez E, Monahan PE, Crary SE, Coppens M, Lemons R, Castaman G, Klamroth R, Symington E, Quon DV, Kampmann P. O'Connell N, et al. Among authors: van der valk p. J Thromb Haemost. 2024 Sep 26:S1538-7836(24)00552-X. doi: 10.1016/j.jtha.2024.08.027. Online ahead of print. J Thromb Haemost. 2024. PMID: 39341368
Clotting factor activity levels and bleeding risk in people with haemophilia playing sports.
Versloot O, Kemler E, Blokzijl J, Timmer M, Schuuring M, van Galen KPM, Kremer Hovinga ICL, van der Valk PR, van Vulpen LFD, Schutgens REG, van Koppenhagen CF, van der Net J, Fischer K. Versloot O, et al. Among authors: van der net j, van der valk pr, van koppenhagen cf, van galen kpm, van vulpen lfd. Haemophilia. 2023 Jul;29(4):1013-1023. doi: 10.1111/hae.14800. Epub 2023 May 24. Haemophilia. 2023. PMID: 37224272
Can motor proficiency testing predict sports injuries and sports-induced bleeds in people with haemophilia?
Versloot O, Blokzijl J, Timmer M, Schuuring M, van Galen K, Kremer Hovinga I, van der Valk P, van Vulpen L, Schutgens R, van Koppenhagen C, van der Net J, Fischer K. Versloot O, et al. Among authors: van der net j, van koppenhagen c, van der valk p, van vulpen l, van galen k. Haemophilia. 2023 May;29(3):864-873. doi: 10.1111/hae.14764. Epub 2023 Mar 3. Haemophilia. 2023. PMID: 36867666
Potential for personalised and biomarker-guided COPD self-treatment approaches.
Lenferink A, Citgez E, van der Valk PDLPM, van der Palen J, Effing TW, Brusse-Keizer MGJ. Lenferink A, et al. Among authors: van der valk pdlpm. Lancet Respir Med. 2024 Aug;12(8):e48-e49. doi: 10.1016/S2213-2600(24)00180-2. Epub 2024 Jun 14. Lancet Respir Med. 2024. PMID: 38885685 No abstract available.
Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptoms.
Citarella BW, Kartsonaki C, Ibáñez-Prada ED, Gonçalves BP, Baruch J, Escher M, Pritchard MG, Wei J, Philippy F, Dagens A, Hall M, Lee J, Kutsogiannis DJ, Wils EJ, Fernandes MA, Tirupakuzhi Vijayaraghavan BK, Panda PK, Martin-Loeches I, Ohshimo S, Fatoni AZ, Horby P, Dunning J, Rello J, Merson L, Rojek A, Vaillant M, Olliaro P, Reyes LF; ISARIC Clinical Characterisation Group. Citarella BW, et al. Heliyon. 2024 May 4;10(10):e29591. doi: 10.1016/j.heliyon.2024.e29591. eCollection 2024 May 30. Heliyon. 2024. PMID: 38779000 Free PMC article.
597 results